Literature DB >> 21412247

Analysis of CYP3A4 genetic polymorphisms in Han Chinese.

Qing Zhou1, Xiaomin Yu, Chang Shu, Yimei Cai, Wei Gong, Xumin Wang, Duen-mei Wang, Songnian Hu.   

Abstract

Our study aimed to comprehensively investigate the genetic polymorphisms of CYP3A4 in Han Chinese. We sequenced the gene regions of CYP3A4, including its promoter, exons, surrounding introns and 3' untranslated region (3'UTR), from 100 unrelated-healthy Han Chinese individuals. We detected 11 SNPs, three of which are novel. According to in silico functional prediction of novel variants, 20148 A>G in exon 10, resulting in substitution of Tyr319 with Cys (CYP3A4*21), may induce dramatic alteration of protein conformation, and 26908 G>A in 3'UTR may disrupt post-transcriptional regulation. We identified five alleles in Han Chinese, the allele frequencies of CYP3A4*1, *5, *6, *18 and *21 are 97, 0.5, 1, 1 and 0.5%, respectively. Haplotype inference revealed 14 haplotypes, of which the major haplotype CYP3A4*1A constitutes 59% of the total chromosomes. We also examined the possible role of natural selection in shaping the variation of CYP3A4 and confirmed a trend, consistent with the action of positive selection. We systematically screened the genetic polymorphisms of CYP3A4 in Han Chinese, highlighted possible functional impairment of the novel allele and summarized the distinct allele and haplotype frequency distribution, with an emphasis on detecting the footprint of recent positive selection on the CYP3A4 gene in Han Chinese.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21412247     DOI: 10.1038/jhg.2011.30

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  13 in total

1.  Role of pharmacogenetics on adjuvant chemotherapy-induced neutropenia in Chinese breast cancer patients.

Authors:  Nelson L S Tang; Chen Di Liao; Xingyan Wang; Frankie K F Mo; Vicky T C Chan; Rita Ng; Elizabeth Pang; Joyce J S Suen; Jean Woo; Winnie Yeo
Journal:  J Cancer Res Clin Oncol       Date:  2012-11-10       Impact factor: 4.553

2.  Polymorphisms and phenotypic analysis of cytochrome P450 3A4 in the Uygur population in northwest China.

Authors:  Tianbo Jin; Hua Yang; Jiayi Zhang; Zulfiya Yunus; Qiang Sun; Tingting Geng; Chao Chen; Jie Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

3.  Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.

Authors:  Wenying Shu; Su Guan; Xiuyan Yang; Liuqin Liang; Jiali Li; Zhuojia Chen; Yu Zhang; Lingyan Chen; Xueding Wang; Min Huang
Journal:  Br J Clin Pharmacol       Date:  2015-12-25       Impact factor: 4.335

4.  Association of CYP3A4, CYP3A5 polymorphisms with lung cancer risk in Bangladeshi population.

Authors:  Mohammad Safiqul Islam; A G M Mostofa; Maizbha Uddin Ahmed; Muhammad Shahdaat Bin Sayeed; Md Rajib Hassan; Abul Hasnat
Journal:  Tumour Biol       Date:  2013-10-02

Review 5.  Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.

Authors:  Tingyu Wang; Yitian Zhou; Guosheng Cao
Journal:  Eur J Clin Pharmacol       Date:  2021-01-29       Impact factor: 2.953

6.  Genotype and Allele Frequency of CYP3A4 -392A>G in Turkish Patients with Major Depressive Disorder.

Authors:  Zuhal Uçkun; Bora Baskak; Hatice Özdemir; Erguvan Tuğba Özel-Kizil; Halise Devrimci-Özgüven; Halit Sinan Süzen
Journal:  Turk J Pharm Sci       Date:  2018-07-17

7.  Distribution of fragile X mental retardation 1 CGG repeat and flanking haplotypes in a large Chinese population.

Authors:  Wen Huang; Qiuping Xia; Shiyu Luo; Hua He; Ting Zhu; Qian Du; Ranhui Duan
Journal:  Mol Genet Genomic Med       Date:  2015-05       Impact factor: 2.183

8.  Association of CYP3A4/5, ABCB1 and ABCC2 polymorphisms and clinical outcomes of Thai breast cancer patients treated with tamoxifen.

Authors:  Insee Sensorn; Ekaphop Sirachainan; Montri Chamnanphon; Ekawat Pasomsub; Narumol Trachu; Porntip Supavilai; Chonlaphat Sukasem; Darawan Pinthong
Journal:  Pharmgenomics Pers Med       Date:  2013-08-26

9.  Effects of cytochrome P450 oxidoreductase genotypes on the pharmacokinetics of amlodipine in healthy Korean subjects.

Authors:  Ji Min Han; Jeong Yee; Jee Eun Chung; Kyung Eun Lee; Kyungsoo Park; Hye Sun Gwak
Journal:  Mol Genet Genomic Med       Date:  2020-03-05       Impact factor: 2.183

10.  Functional characteristics of CYP3A4 allelic variants on the metabolism of loperamide in vitro.

Authors:  Qian-Meng Lin; Ying-Hui Li; Qian Liu; Ni-Hong Pang; Ren-Ai Xu; Jian-Ping Cai; Guo-Xin Hu
Journal:  Infect Drug Resist       Date:  2019-09-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.